About the Journal

Journal of Cancer Therapeutics and Immunotherapy is a biannual, peer-reviewed, open-access journal dedicated to advancing fundamental, translational, and clinical research in cancer biology, oncology, cancer therapeutics, tumor immunology, and immunotherapy. The journal aims to provide a multidisciplinary platform for oncologists, clinicians, immunologists, molecular biologists, pharmacologists, biotechnologists, bioinformaticians, and healthcare researchers to disseminate original scientific findings, emerging therapeutic approaches, and critical insights into cancer prevention, diagnosis, treatment, and patient management. The journal particularly encourages research focused on cancer immunotherapy, precision oncology, molecularly targeted therapies, cellular and gene-based treatments, tumor microenvironment, cancer biomarkers, treatment resistance, and personalized therapeutic strategies. Recognizing the increasing importance of molecular technologies and computational approaches in cancer research, the journal welcomes studies integrating genomics, transcriptomics, proteomics, metabolomics, single-cell analysis, spatial biology, artificial intelligence, and multi-omics methodologies with cancer therapeutics and clinical oncology. The journal seeks to bridge fundamental discoveries and clinical applications by promoting research on novel anticancer agents, therapeutic mechanisms, treatment effectiveness, drug resistance, clinical trials, and innovative approaches to cancer care.

Through original research, clinical investigations, experimental studies, narrative reviews, systematic reviews, and other scholarly contributions, the journal aims to advance scientific understanding and support the development of safer, more effective, accessible, and personalized cancer treatments.


We accept a diverse range of scholarly contributions, including Original Research Articles, Review Articles, Short Communications, Case reports, Mini Reviews, and Perspective/Opinion Papers.


You can submit your manuscript online at: https://www.reseaprojournals.com/submit-manuscript, or send it as an email attachment to editorial.jctai@reseaprojournals.com

Journal Overview Details
Starting year 2024
Frequency Biannual
Format Online
Subject Medical Science
Language of publication English

Loading publication timeline...

WhatsApp Chat